Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02090634 · ClinicalTrials.gov registry record · NA
Texting to Improve Adherence in HIV+ With Bipolar Disorder
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02090634 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 58 participants.
The verdict
NCT02090634, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
Adherence to combination antiretroviral therapy (ART) is critical for successful HIV viral suppression. Nonadherence to ART poses several potentially serious health consequences, including higher viral loads, faster progression to AIDS, and a heightened risk of viral mutations, treatment resistance and HIV transmission. The prevalence of serious mental illness (SMI) conditions, including bipolar disorder (BD), is elevated among HIV-infected populations and is associated with poor ART adherence. HIV-infected individuals with co-occurring BD (HIV+/BD+), when compared to demographically similar HIV+/BD- persons, demonstrated poorer ART and psychotropic medication adherence and were twice as likely to be non adherent to their ART regimen using a ≥ 90% cutoff score. HIV+/BD+ individuals are particularly at-risk for medication non adherence, and there is a critical need to develop interventions to improve adherence in this population. Poor psychotropic medication adherence is also common among people with SMI - it has been estimated that 40% of those with BD do not take their mood stabilizer as prescribed. Among persons with BD, nonadherence to psychotropic medications can lead to greater risk for manic and depressive episodes, decreased quality of life, suicide attempts, and hospitalization. The utilization of mobile health (i.e., mHealth) technologies to improve everyday functioning is growing. mHealth interventions capitalize on technology already incorporated into most people's daily lives (e.g., cell phones) to assist people with behavior modification and disease self-management. Text messaging, in particular, may support daily ART adherence by delivering reminders at precise times to match an individuals' dosing schedule. The initial evidence for using text messaging to improve ART medication adherence has been compelling. Researchers and clinicians have also started employing technology-based approaches to improve treatment for individuals with BD. Taken togeth
Interventions
- BEHAVIORAL Psychoeducation
- BEHAVIORAL individualized Texting for Adherence Building (iTAB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02090634
The ClinicalTrials.gov registry entry for NCT02090634 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Psychoeducation is the first listed.
NCT02090634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02090634 about?
NCT02090634 is a clinical study titled "Texting to Improve Adherence in HIV+ With Bipolar Disorder". Adherence to combination antiretroviral therapy (ART) is critical for successful HIV viral suppression. Nonadherence to ART poses several potentially serious health consequences, including higher viral loads, faster progression to AIDS, and a heightened risk of viral mutations, treatment resistance ...
What is the current status of trial NCT02090634?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2010-04. Estimated completion is 2012-03.
What interventions are being tested in trial NCT02090634?
The interventions under investigation include: Psychoeducation (BEHAVIORAL), individualized Texting for Adherence Building (iTAB) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02090634?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.